Cargando…

New Technologies for Influenza Vaccines

Vaccine development has been hampered by the long lead times and the high cost required to reach the market. The 2020 pandemic, caused by a new coronavirus (SARS-CoV-2) that was first reported in late 2019, has seen unprecedented rapid activity to generate a vaccine, which belies the traditional vac...

Descripción completa

Detalles Bibliográficos
Autores principales: Rockman, Steven, Laurie, Karen L., Parkes, Simone, Wheatley, Adam, Barr, Ian G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7694987/
https://www.ncbi.nlm.nih.gov/pubmed/33172191
http://dx.doi.org/10.3390/microorganisms8111745